polymerase beta. J. Biol.
Chem. 278(20):18471-18477.
Turturro, F., et al. (2002) Model of inhibition of the NPM-ALK kinase activity by herbimycin A. Clin.
Cancer Res. 8(1):240-245 (cites the use of this
II. Suitable for the
dephosphorylation of phosphotyrosine residues in substrate proteins.
20 µg 214
Protein Tyrosine
Phosphatase PRL-3,
GST-Fusion, Human,
Recombinant, E. coli
539807 The catalytic
other use of the CMV promoter requires a license from the University
of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242, USA.
Use of IRES is covered by U.S. Patent 4
Proc. Natl. Acad. Sci. USA 101, 7578; Liu, M ., et al . 2003 . J. Biol. Chem. 278, 1594; Tanaka, K ., et al .
1998 . Mol. Cells 8, 503 .
UbcH9 Conjugating Enzyme, Human, Recombinant
other use of the CMV promoter requires a license from the University
of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242, USA.
Use of IRES is covered by U.S. Patent 4
enzyme that
will hydrolyze 1.0 nmol of pNPP per minute at 30°C. M.W. 60,300
Cat. No. 535857 20 mg € 214
Ref.: Huynh, H., et al. 2003. J. Immunol. 171, 6661; Qi, Y., et al. 2002. J. Cell Biochem. 86